Summary
Akers Biosciences, Inc. (ABI) is a medical device company that develops, manufactures and supplies in vitro diagnostic technologies. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, PIFA Heparin, and breath ketone. ABI provides testing platform technologies that include MPC biosensor, particle immune-filtration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. It provides its products to healthcare facilities. ABI is headquartered in West Deptford, New Jersey, the US.
Akers Biosciences Inc (AKER) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Akers Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Akers Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Akers Biosciences Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Akers Biosciences Acquires Technology Assets From Pulse Health 11
Partnerships 12
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12
Akers Biosciences Enters into Distribution Agreement with Aero-Med 12
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 13
Akers Biosciences Enters into Distribution Agreement with Medline Industries 14
Akers Biosciences Enters into Distribution Agreement with Typenex 14
Equity Offering 15
Akers Biosciences to Raise USD2 Million in Private Placement of Shares 15
Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 16
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 17
Akers Biosciences Completes Private Placement Of US$3.2 Million 18
Akers Biosciences Inc - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 23
Nov 14, 2016: Akers Biosciences Announces Q3 Earnings 25
Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings 27
May 12, 2016: Akers Biosciences: Financial Results for the First Quarter 2016 29
May 12, 2016: Akers Biosciences Reports Earnings for Q1 2016 31
Mar 30, 2016: Akers Biosciences Reports Earnings for Fiscal Year 2015 34
Corporate Communications 38
Apr 29, 2016: Akers Board Rearrangement 38
Apr 25, 2016: Akers Biosciences: Board Rearrangement 39
Feb 29, 2016: Akers Biosciences Hires Leading Commercial Executives to Support Sales Growth 40
Legal and Regulatory 41
Aug 19, 2016: Akers Biosciences Announces Settlement of Dispute with ChubeWorkx 41
Product News 42
03/23/2016: Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection 42
03/02/2016: Akers Biosciences Announces $2.5M Order to Supply PIFA Heparin/PF4 Products to China 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
Akers Biosciences Inc, Medical Equipment, Key Facts, 2015 1
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Akers Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Akers Biosciences Inc, Deals By Market, 2011 to YTD 2017 9
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Akers Biosciences Acquires Technology Assets From Pulse Health 11
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12
Akers Biosciences Enters into Distribution Agreement with Aero-Med 12
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 13
Akers Biosciences Enters into Distribution Agreement with Medline Industries 14
Akers Biosciences Enters into Distribution Agreement with Typenex 14
Akers Biosciences to Raise USD2 Million in Private Placement of Shares 15
Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 16
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 17
Akers Biosciences Completes Private Placement Of US$3.2 Million 18
Akers Biosciences Inc, Key Competitors 20
Akers Biosciences Inc, Key Employees 21
Akers Biosciences Inc, Subsidiaries 22
List of Figures
Akers Biosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Akers Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Akers Biosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Akers Biosciences Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
